Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:00 PM UTC
| NCT Number | NCT06072612 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE3 |
| Target Enrollment | 404 participants |
| Active Locations | 79 sites in the US |
| Sponsor | BriaCell Therapeutics Corporation |
| Last Updated on CT.gov | September 2, 2026 (Sep 2, 2026) |
As of October 15, 2026: Clinical trial NCT06072612 is currently recruiting participants. This phase3 study for breast cancer is actively seeking new participants at 79 locations across the United States. The study is sponsored by BriaCell Therapeutics Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06072612 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 79 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06072612 was last updated Sep 2, 2026 (September 2, 2026). HelloStudys verifies this status automatically.